BUY Hero MotoCorp — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))3 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
4 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·4 Aug · today
Nifty rally has enough steam left to move closer to 25,000
NewsEt-Markets·3 Aug · yesterday
Nifty rally has enough steam left to move closer to 25,000: Analysts
NewsEt-Markets·3 Aug · yesterday
Hero MotoCorp reported a 19% year-on-year growth in total dispatches for July 2026, reaching 533,416 units. The company also expanded its global presence by entering Ecuador and Germany, and laid the
BSE · Company Update·1 Aug · 2d ago
July Auto Sales Highlights: Maruti Suzuki Production Rises 33%, Hero MotoCorp Total Sales Up 19%
NewsNdtv-Profit·1 Aug · 3d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Hero MotoCorp
- BUY — Aditya Agarwal, Coheron Brokers22 Oct 2026 · ~2 weeks · target ₹5,600 · Active
- BUY — Sahaj Agrawal, Kotak Securities21 Oct 2026 · ~2 weeks · target ₹5,400 · SL hit
- BUY — Rakesh Bansal19 Oct 2026 · Same day · target ₹5,318 · SL hit
- BUY — Siddharth Sedani, Anand Rathi16 Oct 2026 · Same day · target ₹5,300 · Expired
- BUY — Rachna Vaidya14 Oct 2026 · Same day · target ₹5,100 · SL hit
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

